Grace Therapeutics, Inc. (GRCE) — Cash Flow Quality Index

Latest as of March 2025: -4.64x

Grace Therapeutics, Inc. (GRCE) has a Cash Flow Quality Index of -4.64x as of March 2025. Operating cash flow of $-2.95 Million is below net income of $636.00K, suggesting accrual-heavy earnings not yet converted to cash. Also explore GRCE asset base for the complete picture of this company's asset base.

Cash Flow Quality Index

-4.64x
Operating CF / Net Income

Operating Cash Flow

$-2.95 Million
USD

Net Income

$636.00K
USD

Data as of

Mar 2025
Most recent filing

Annual Cash Flow Quality Index for Grace Therapeutics, Inc. (None–None)

Year-by-year earnings quality comparison for Grace Therapeutics, Inc.. For live market cap and the full company financial profile, see market value of Grace Therapeutics, Inc..

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.